Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksApq Global Regulatory News (APQ)

  • There is currently no data for APQ

Trading Update

3 Apr 2024 07:00

RNS Number : 0063J
APQ Global Limited
03 April 2024
 

APQ Global Limited

 

("APQ Global" or the "Company")

 

Trading Update

 

APQ Global Limited, a company incorporated in Guernsey (company registration number 62008) which is listed on The International Stock Exchange and admitted to trading on AIM, today announces an update on trading for the period ended 31 December 2023 and 2024 year to date.

 

Highlights

· As announced on 22 March 2024, APQ's unaudited book value per Ordinary Share as at 29 February 2024 was 30.20 US Dollar cents (equivalent to 23.97 Pounds Sterling pence).

· This book value increase was substantially driven by the strong trading performance in APQ's direct investment in US-based capital raising and transaction advisory business Delphos International. This resulted in a significant increase in Delphos' independent third-party revaluation undertaken as part of APQ's 2023 financial year end audit process currently underway, from c.USD 6.3m at 31 December 2022 to c.USD 27.0m at 31 December 2023 (unaudited).

· Delphos International's trading highlights include:

Revenues increased by 145% between 2022 and 2023 calendar years

The business reached meaningful profitability for the first time in 2023

Current trading in 2024 continues to be strong, and its management team expects the business to exhibit further significant year on year growth in revenue and profits, with an attractive pipeline of transaction mandates under way

· The unaudited third-party valuation of APQ's investments in Parish Group and Delphos Canada also increased over the period to 31 December 2023, and the Board believes the outlook for these and APQ's other unlisted portfolio companies remains favourable for the remainder of 2024.

 

- End -

 

For further enquiries, please contact:

 

APQ Global Limited Bart Turtelboom

020 3478 9708

 

Singer Capital Markets - Nominated Adviser and Broker James Maxwell

020 7496 3000

Suntera - TISE sponsor Claire Torode

01481 737 277

Investor Relations

IR@APQGlobal.com

 

 

Notes to Editors

 

 

APQ Global Limited

 

APQ Global (ticker: APQ LN) is an investment company incorporated in Guernsey. The Company focuses its investment activities globally (in Asia, Latin America, Eastern Europe, the Middle East, Africa and the Channel Islands, particularly). The objective of the Company is to steadily grow its earnings to seek to deliver attractive returns and capital growth through a combination of building growing businesses as well as earning revenue from income generating operating activities in capital markets1. APQ Global run a well-diversified and liquid portfolio, take strategic stakes in selected businesses and plan to take operational control of companies through the acquisition of minority and majority stakes in companies with a focus on emerging markets. For more information, please visit apqglobal.com.

1 Where we refer to revenue from income generating operating activities this relates to the revenue of our investee companies.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTSSFFDEELSEDL
Date   Source Headline
15th Nov 20177:00 amRNSBook Value Report
31st Oct 20177:00 amRNSNew appointment to Advisory Council
19th Oct 20177:00 amRNSOutlook
19th Oct 20177:00 amRNSDividend Declaration
19th Oct 20177:00 amRNSQuarterly Update
16th Oct 20177:00 amRNSBook Value Report
12th Oct 20177:00 amRNSNew appointment to Advisory Council
9th Oct 20177:00 amRNSAdvisory Council further strengthened
26th Sep 201711:23 amRNSInterim Results for the Period to 30 June 2017
15th Sep 20177:00 amRNSBook Value Report
6th Sep 20175:00 pmRNSTrading in CULS
4th Sep 20172:00 pmRNSResults of Extraordinary General Meeting
16th Aug 20177:00 amRNS2017 Mid-Year Review
15th Aug 20177:05 amRNSSuccessful Fundraising
15th Aug 20177:00 amRNSBook Value Report
8th Aug 20173:00 pmRNSResult of AGM
8th Aug 20177:46 amRNSAppointment to the International Advisory Council
17th Jul 20177:00 amRNSQuarterly Update
17th Jul 20177:00 amRNSDividend Declaration
17th Jul 20177:00 amRNSPublication of Annual Report and Notice of AGM
17th Jul 20177:00 amRNSBook Value Report
12th Jul 20177:00 amRNSAppointments to the International Advisory Council
29th Jun 20175:56 pmRNSReport and Accounts
15th Jun 20177:00 amRNSBook Value Report
15th Jun 20177:00 amRNSPotential Capital Raise
13th Jun 20177:00 amRNSPotential Capital Raise
15th May 20177:00 amRNSBook Value Report
20th Apr 20174:45 pmRNSQuarterly Update
20th Apr 20174:45 pmRNSDividend Declaration
18th Apr 20177:00 amRNSBook Value Report
15th Mar 20177:00 amRNSBook Value Report
15th Feb 20177:00 amRNSBook Value Report
10th Feb 20177:00 amRNSOutlook
16th Jan 20177:00 amRNSQuarterly Update
16th Jan 20177:00 amRNSDividend Declaration
16th Jan 20177:00 amRNSBook value report
15th Dec 20167:00 amRNSBook value report
8th Dec 20165:30 pmRNSDirector/PDMR Shareholding
15th Nov 20167:00 amRNSBook value announcement
28th Oct 20167:00 amRNSQuarterly Update
17th Oct 20167:00 amRNSBook value report
19th Sep 201611:01 amRNSTR-1: Notification of Major Interest in Shares
26th Aug 20167:00 amRNSAdmission to trading on AIM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.